Summit Therapeutics Inc (NAS:SMMT)
$ 17.52 -0.25 (-1.41%) Market Cap: 12.91 Bil Enterprise Value: 12.75 Bil PE Ratio: 0 PB Ratio: 29.66 GF Score: 30/100